ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3
Cellular Oncology · 2026
DOI: 10.1007/s13402-025-01144-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Quhui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Hospital of Nantong University, Medical College of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, HSC70 Heat-Shock Proteins, Ubiquitination. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In this study, we examined the biological significance of the actin gamma 1 (ACTG1)-UCHL3–HSPA8 axis in breast cancer. Through bioinformatic analysis, we recognized ACTG1 as a potential oncogenic factor in BRCA. By exploiting qRT-qPCR and Western blot analysis, we assessed the expression of ACTG1 and explored its impact on cellular proliferation, migration, and invasion. Our findings suggest that ACTG1 exerts its oncogenic effects in breast cancer cells through the EMT signaling pathway. By mining the BIOGRID database, we identified potential downstream regulatory genes; and co-immunoprecipitation assays confirmed protein interactions between ACTG1 and HSPA8. We also observed that ACTG1 promoted breast cancer cell proliferation, invasion, and migration via its interaction with HSPA8. Importantly, our study elucidated the facilitation by UCHL3 of HSPA8 deubiquitination by ACTG1. In conclusion, our study revealed a key role played by the ACTG1–UCHL3–HSPA8 axis in driving breast cancer progression as well as the role of ribociclib resistance. Our findings provide compelling evidence for the therapeutic potential of targeting this axis in breast cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Affiliated Hospital of Nantong University, Medical College of Nantong University, Nantong, China.
- Department of Radiation Oncology, Affiliated Hospital of Nantong University, Medical College of Nantong University, Nantong, China.
- Department of General Surgery, Huaian Hospital of Huaian City, Huaian, China.
- Department of General Surgery, Yancheng City No.1 People's Hospital, The Fourth Affiliated Hospital of Nantong University, Yancheng, China.
- Department of General Surgery, Affiliated Hospital of Nantong University, Medical College of Nantong University, Nantong, China. hezhixaings@sina.com.
- Department of General Surgery, Nantong Tongzhou People's Hospital, Nantong, China. cyf755755@163.com.
Zitieren
APA
Wang, Q., Liu, X., Yang, X., He, Z., & Chen, Y. (2026). ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3. Cellular Oncology. https://doi.org/10.1007/s13402-025-01144-8
Vancouver
Wang Q, Liu X, Yang X, He Z, Chen Y. ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3. Cellular Oncology. 2026. doi:10.1007/s13402-025-01144-8
BibTeX
@article{Wang2026,
author = {Wang, Quhui and Liu, Xiancheng and Yang, Xiaobing and He, Zhixian and Chen, Yangfeng},
title = {ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-025-01144-8}
}
EUVIMED